 <h1>CaroSpir Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>spironolactone</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about spironolactone. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name CaroSpir.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to spironolactone: oral suspension, oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, spironolactone (the active ingredient contained in CaroSpir) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking spironolactone:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Bleeding gums</li>
<li>bloody or black, tarry stools</li>
<li>bloody urine</li>
<li>blurred vision</li>
<li>breast pain</li>
<li>chest pain</li>
<li>clay-colored stools</li>
<li>clear or bloody discharge from the nipple</li>
<li>cloudy urine</li>
<li>confusion</li>
<li>constipation</li>
<li>cough</li>
<li>dark urine</li>
<li>decrease in urine output or decrease in urine-concentrating ability</li>
<li>diarrhea</li>
<li>difficulty with swallowing</li>
<li>dimpling of the breast skin</li>
<li>dizziness</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>drowsiness</li>
<li>fast or irregular heartbeat</li>
<li>fever with or without chills</li>
<li>general feeling of tiredness or weakness</li>
<li>headache</li>
<li>heartburn</li>
<li>hives, itching, or skin rash</li>
<li>hoarseness</li>
<li>increased thirst</li>
<li>indigestion</li>
<li>inverted nipple</li>
<li>loss of appetite</li>
<li>loss of consciousness</li>
<li>lower back or side pain</li>
<li>lump in the breast or under the arm</li>
<li>muscle pain or cramps</li>
<li>muscle spasms or twitching</li>
<li>nausea</li>
<li>painful or difficult urination</li>
<li>persistent crusting or scaling of the nipple</li>
<li>pinpoint red spots on the skin</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>redness or swelling of the breast</li>
<li>seizures</li>
<li>severe stomach pain</li>
<li>shakiness and unsteady walk</li>
<li>sore on the skin of the breast that does not heal</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stomach cramping, burning, or tenderness</li>
<li>swelling of the face, fingers, feet, ankles, or lower legs</li>
<li>swollen, painful, or tender lymph glands in the neck, armpit, or groin</li>
<li>tightness in the chest</li>
<li>trembling</li>
<li>troubled breathing</li>
<li>unpleasant breath odor</li>
<li>unsteadiness, trembling, or other problems with muscle control or coordination</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
<li>weight gain</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking spironolactone:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Irregular heartbeat</li>
<li>nervousness</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>rash with flat lesions or small raised lesions on the skin</li>
<li>reddened skin</li>
<li>weakness or heaviness of the legs</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of spironolactone may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Burning feeling in the chest or stomach</li>
<li>decreased interest in sexual intercourse</li>
<li>hair loss or thinning of the hair</li>
<li>inability to have or keep an erection</li>
<li>leg cramps</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>pain in the nipples</li>
<li>sores, welts, or blisters</li>
<li>stomach upset</li>
<li>swelling of the breasts or breast soreness in both females and males</li>
<li>unusual dullness or feeling of sluggishness</li>
</ul><p>
<!-- end oral suspension, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to spironolactone: compounding powder, oral suspension, oral tablet</i></p><h3>General</h3><p>The most common adverse effect was gynecomastia.<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Gynecomastia (13%)</p>
<p><b>Frequency not reported</b>: Breast disorders in women, slight androgenic effects, breast tenderness in women, voice deepening in women, breast pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperkalemia, hyponatremia</p>
<p><b>Uncommon</b> (0.1% to 1%): Acidosis in patients with liver problems</p>
<p><b>Rare</b> (less than 0.1%): Dehydration, porphyria, hyperuricemia</p>
<p><b>Frequency not reported</b>: Reversible hyperchloremic metabolic acidosis in patients with decompensated hepatic cirrhosis, electrolyte disturbances<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Changes in vaginal secretions, amenorrhea, postmenopausal bleeding</p>
<p><b>Frequency not reported</b>: Reproductive system disorders, erectile dysfunction, impotence, menstrual disorders<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Lethargy in patients with cirrhosis, paresthesia</p>
<p><b>Rare</b> (less than 0.1%): Paralysis, paraplegia of the limbs due to hyperkalemia</p>
<p><b>Frequency not reported</b>: Headache, drowsiness, dizziness, ataxia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting</p>
<p><b>Very rare</b> (less than 0.01%): Gastric inflammation, gastric ulcers, intestinal hemorrhage, cramps</p>
<p><b>Frequency not reported</b>: Digestive system disorders, diarrhea, indigestion, gastric bleeding<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Libido reduced in women</p>
<p><b>Uncommon</b> (0.1% to 1%): Confusion</p>
<p><b>Frequency not reported</b>: Libido reduced in men<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Malaise</p>
<p><b>Very rare</b> (less than 0.01%): Breast cancer<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Weakness</p>
<p><b>Frequency not reported</b>: Fatigue, fever<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, urticaria, erythema, chloasma, pruritus, exanthema</p>
<p><b>Rare</b> (less than 0.1%): Eczema</p>
<p><b>Very rare</b> (less than 0.01%): Alopecia, erythema annulare centrifugum, hypertrichosis</p>
<p><b>Frequency not reported</b>: Hirsutism, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms (DRESS), maculopapular or erythematous cutaneous eruptions<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Muscle spasms, leg cramps</p>
<p><b>Very rare</b> (less than 0.01%): Systemic lupus erythematosus, osteomalacia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Serum creatinine elevated</p>
<p><b>Rare</b> (less than 0.1%): BUN increased</p>
<p><b>Very rare</b> (less than 0.01%): Acute renal failure</p>
<p><b>Frequency not reported</b>: Renal dysfunction<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Thrombocytopenia, eosinophilia, leukopenia</p>
<p><b>Frequency not reported</b>: Agranulocytosis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity</p>
<p><b>Frequency not reported</b>: Anaphylactic reactions<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very rare</b> (less than 0.01%): Vasculitis</p>
<p><b>Frequency not reported</b>: Mild hypotension<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very rare</b> (less than 0.01%): Hepatitis</p>
<p><b>Frequency not reported</b>: Mixed cholestatic/hepatocellular toxicity<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Aldactone (spironolactone)." Searle, Skokie, IL. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What is the strength of CaroSpir (spironolactone) oral suspension?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about CaroSpir (spironolactone)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: aldosterone receptor antagonists</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Carospir &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Aldactone</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Edema</li>
<li>Heart Failure</li>
<li>High Blood Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to spironolactone: compounding powder, oral suspension, oral tablet</i></p><h3>General</h3><p>The most common adverse effect was gynecomastia.<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Gynecomastia (13%)</p><p><b>Frequency not reported</b>: Breast disorders in women, slight androgenic effects, breast tenderness in women, voice deepening in women, breast pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperkalemia, hyponatremia</p><p><b>Uncommon</b> (0.1% to 1%): Acidosis in patients with liver problems</p><p><b>Rare</b> (less than 0.1%): Dehydration, porphyria, hyperuricemia</p><p><b>Frequency not reported</b>: Reversible hyperchloremic metabolic acidosis in patients with decompensated hepatic cirrhosis, electrolyte disturbances<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Changes in vaginal secretions, amenorrhea, postmenopausal bleeding</p><p><b>Frequency not reported</b>: Reproductive system disorders, erectile dysfunction, impotence, menstrual disorders<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Lethargy in patients with cirrhosis, paresthesia</p><p><b>Rare</b> (less than 0.1%): Paralysis, paraplegia of the limbs due to hyperkalemia</p><p><b>Frequency not reported</b>: Headache, drowsiness, dizziness, ataxia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting</p><p><b>Very rare</b> (less than 0.01%): Gastric inflammation, gastric ulcers, intestinal hemorrhage, cramps</p><p><b>Frequency not reported</b>: Digestive system disorders, diarrhea, indigestion, gastric bleeding<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Libido reduced in women</p><p><b>Uncommon</b> (0.1% to 1%): Confusion</p><p><b>Frequency not reported</b>: Libido reduced in men<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Malaise</p><p><b>Very rare</b> (less than 0.01%): Breast cancer<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Weakness</p><p><b>Frequency not reported</b>: Fatigue, fever<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, urticaria, erythema, chloasma, pruritus, exanthema</p><p><b>Rare</b> (less than 0.1%): Eczema</p><p><b>Very rare</b> (less than 0.01%): Alopecia, erythema annulare centrifugum, hypertrichosis</p><p><b>Frequency not reported</b>: Hirsutism, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms (DRESS), maculopapular or erythematous cutaneous eruptions<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Muscle spasms, leg cramps</p><p><b>Very rare</b> (less than 0.01%): Systemic lupus erythematosus, osteomalacia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Serum creatinine elevated</p><p><b>Rare</b> (less than 0.1%): BUN increased</p><p><b>Very rare</b> (less than 0.01%): Acute renal failure</p><p><b>Frequency not reported</b>: Renal dysfunction<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Thrombocytopenia, eosinophilia, leukopenia</p><p><b>Frequency not reported</b>: Agranulocytosis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity</p><p><b>Frequency not reported</b>: Anaphylactic reactions<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very rare</b> (less than 0.01%): Vasculitis</p><p><b>Frequency not reported</b>: Mild hypotension<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very rare</b> (less than 0.01%): Hepatitis</p><p><b>Frequency not reported</b>: Mixed cholestatic/hepatocellular toxicity<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Aldactone (spironolactone)." Searle, Skokie, IL. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is the strength of CaroSpir (spironolactone) oral suspension?</li>
</ul><h2>More about CaroSpir (spironolactone)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: aldosterone receptor antagonists</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Carospir &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Edema</li>
<li>Heart Failure</li>
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>